-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

626. Aggressive Lymphomas: Clinical and Epidemiological: Poster III

Symposia: Aggressive Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Eduardo Edelman Saul, MD1, Bryan Valcarcel, MD, MPH2, Amy A. Ayers, MPH3*, Mansoor Noorani, MD3*, Dai Chihara, MD, PhD3, Fateeha Furqan, MBBS3, Sairah Ahmed, MD3, Swaminathan P Iyer, MD3*, Sattva S. Neelapu, MD3, Luis E. Fayad, MD3, F. B. Hagemeister, MD3, Chijioke Nze, MD, MPH3, Preetesh Jain, MD, MBBS, PhD, DM3, Michael Wang, MD3, Paolo Strati, MD3, Ayushi Chauhan, MD3, Francisco Vega, MD, PhD4, Christopher R. Flowers, MD, MS3 and Jason R. Westin, MD3

1Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
2Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Houston, TX
3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Chen Zhang1*, Jili Deng2*, Lan Mi3*, Jiayue Qin, PhD4*, Lixia Liu4* and Yuqin Song, MD5

1Peking University Cancer Hospital and Institute, Beijing, AL, CHN
2Department of Oncology, Sichuan Cancer Hospital and Institute, Chengdu, China
3Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China
4Acornmed Biotechnology Co., Ltd., Beijing, China
5Department of Lymphoma, Peking University Cancer Hospital, BEIJING, China

Lynda M Villagomez, MD1 and Joseph R Stanek, MS2*

1Department of Pediatrics, Division of Hematology and Oncology, Nationwide Children's Hospital and The Ohio State University, Bexley, OH
2Division of Pediatric Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH

Shaojie Wu1*, Yanni Deng2*, Mingyao Lai3*, Sanfang Tu4*, Linbo Cai5* and Yuhua Li4*

1Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, AL, China
2Department of Hematology,ZhuJiang Hospital of Southern Medical University, Guangzhou, China
3Guangdong Sanjiu Brain Hospital, Guangdong Sanjiu Brain Hospital, Guangzhou, China
4Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, China
5Guangdong Sanjiu Brain Hospital, guangzhou, China

Luís Alberto de Pádua Covas Lage, MD, PhD1*, Rita Novello de Vita2*, Cadiele Oliana Reichert, MSc, PhD1*, Hebert Fabrício Culler, MSc, PhD3*, Fábio Alessandro de Freitas, MSc, PhD1*, Lucas Bassolli De Oliveira Alves4*, Mayara D’Auria Jacomassi2*, Vanderson Rocha, MD, PhD, MS1,5,6,7,8,9,10*, Sheila Aparecida Coelho da Siqueira, MD, PhD11*, Renata de Oliveira Costa, MD, PhD12 and Juliana Pereira, MD, PhD1

1University of São Paulo, Department of Hematology, Hemotherapy & Cell Therapy, University of São Paulo, São Paulo, São Paulo, Brazil
2Department of Hematology, Hemotherapy & Cell Therapy, University of São Paulo, São Paulo, Brazil
3University of São Paulo, Department of Hematology, Hemotherapy & Cell Therapy, University of São Paulo, São Paulo, São Paulo, BRA
4Department of Hematology, Hemotherapy & Cell Therapy, University of São Paulo, Sao Paulo, Brazil
5Hospital das Clínicas, University of Sao Paulo, São Paulo, Brazil
6Service of Hematology, Transfusion and Cell Therapy, and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Hospital das Clínicas, Faculty of Medicine, São Paulo University, São Paulo, Brazil., São Paulo, Brazil
7Hematology, Hospital das Clinicas - University of Sao Paulo Medical School, Sao Paulo, Brazil
8Sírio Libanês Hospital, São Paulo, PB, BRA
9Instituto do Câncer do Estado de São Paulo, University of São Paulo, São Paulo, Brazil
10Eurocord, Hôpital Saint Louis APHP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris Cité, Paris, France
11University of São Paulo, Department of Pathology, University of São Paulo, São Paulo, São Paulo, Brazil
12Centro Universitário Lusíadas, Department of Hematology, Faculdade de Ciências Médicas de Santos, Santos, São Paulo, Brazil

Hideki Uryu, MD1*, Masaharu Kawashima, MD, PhD2*, Kazuhito Suzuki, MD, PhD1, Ryoko Fukushima, MD, PhD3*, Tadahiro Gunji, MD2*, Hiroto Ishii, MD, PhD3*, Kei Hirano, MD3*, Riku Nagao, MD3*, Hiroki Yokoyama, MD, PhD1*, Atsushi Katsube, MD1*, Susumu Tanoue, MD, PhD1*, Yo Sakayori, MD1*, Yasutaka Mochizuki, MD1*, Keita Ishii, MD1*, Rie Ohba, MD, PhD2*, Kurumi Tsukamoto, MD2*, Daiki Hattori, MD2*, Mitsuji Katori, MD, PhD3*, Takeshi Saito, MD, PhD1, Kaichi Nishiwaki, MD, PhD3*, Nobuaki Dobashi, MD, PhD2 and Shingo Yano, MD, PhD1

1Division of Clinical Oncology/Hematology, The Jikei University Hospital, Tokyo, Japan
2Division of Clinical Oncology/Hematology, The Jikei University Daisan Hospital, Tokyo, Japan
3Division of Clinical Oncology/Hematology, The Jikei University Kashiwa Hospital, Chiba, Japan

Sonia Godbole, MD1, Rina Li Welkie, MPH2, Audrey M. Sigmund, MD3, Timothy Voorhees, MD, MSc4, Walter Hanel, MD, PhD5, David A. Bond, MD, BS4, John C. Reneau, MD, PhD6, Lapo Alinari, MD, Ph.D7, Jonathan E. Brammer4, Beth Christian, MD4, Robert Baiocchi, MD, PhD7, Kami J. Maddocks, MD8 and Yazeed Sawalha, MD4

1Division of Hematology, Ohio State University, Columbus, OH
2The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH
3James Comprehensive Cancer Center, The Ohio State University, Columbus
4Division of Hematology, The Ohio State University, Columbus, OH
5James Comprehensive Cancer Center, The Ohio State University, Dublin, OH
6The James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
7James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
8The James Cancer Center, The Ohio State University, Columbus, OH

Shruti Prem Sudha, MD, MBBS, DM, Fatima Al-ali*, Atef Shehata*, Nabil Abdelfattah*, Taif Najeebi*, Cigdem Ozturk*, Aly Sobhy Rashed*, Manu Venkatesan* and Rehab Helmy*

Bahrain Oncology Center, Muharraq, Bahrain

Dai Chihara, MD, PhD1, Micheal J. Kane, PhD1*, Christopher R. Flowers, MD, MS1 and Brian P. Hobbs, PhD2*

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2Telperian Inc, Austin, TX

Andres Bravo-Gonzalez, MD1*, Maria Paula Alviar-Ortiz2*, Elsa Vasquez-Trespalacios2* and Georgios Pongas, MD3

1London School of Hygiene and Tropical Medicine, Bogotá, Colombia
2CES University, Medellin, Colombia
3Sylvester Comprehensive Cancer Center, Miami

Sina Alexandra Beer1*, Carola Huber, MD2*, Michael Sommer, MD2*, Stefan Wirths, MD3*, Daniela Süsskind, MD4*, Claudia Lengerke, MD5 and David Adrian Merle, MD4*

1Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, AL, Germany
2Department of Ophthalmology, Medical University Graz, Graz, Austria
3Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
4Department of Ophthalmology, University Hospital Tuebingen, Tuebingen, Germany
5Department of Oncology, Hematology, Clinical Immunology, and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany

Mohammad Ma'koseh, MD1,2*, Abeer Yaseen, MD3*, Nebras Abu Abed, MD4*, Omar Ahmad Shahin, MD5*, Alaa Abufara, MD5*, Khalid Halahleh, MD6*, Mohammad Al-Rwashdeh, MD5*, Zaid Abdel Rahman, MD7,8, Kamal Al-Rabi, MD1* and Hikmat Abdel-Razeq, MD1,8*

1King Hussein Cancer Center, Amman, Jordan
2College of Medicine, University of Jordan, Amman, Jordan
3KIng Hussein Cancer Center, Amman, Jordan
4King Hussein Cancer Center, Jubeiha, Jordan
5king Hussein cancer center internal medicine department, Amman, Jordan
6King Hussein Cancer Centre Adult BMT Program, Amman, Jordan
7Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan
8University of Jordan, Amman, Jordan

Chieh-Lung Cheng, MD, PhD1*, Su-Mei Wang2*, Yu-Hsuan Tuan1*, Jung-Fang Liang3*, Anita Chen4*, Yun-Chun Wu, PhD5*, Chin-Hao Chang6* and Tai-Chung Huang, MD7

1National Taiwan University Hospital, Taipei, Taiwan
2National Taiwan University Hospital, Taiepi, Taiwan
3National Taiwan University Hospital, Taipie, Taiwan
4Roche Product Ltd.,Taiwan, Taipei, Taiwan
5Roche Product Ltd.,Taiwan, Taipei City, TWN
6National Taiwan University College of Medicine, Taipei, TWN
7Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

Jean-Marie Michot1*, Cédric Portugues2*, Lucie Oberic, MD3*, Fabrice Jardin, MD, PhD4*, Vincent Delwail, MD5*, Vincent Camus, MD, PhD6*, Franck Morschhauser7, Catherine Thieblemont, MD8, Corinne Haioun, MD, PhD9, Frederic Peyrade, MD10* and Hervé Tilly4

1Gustave Roussy Cancer Campus, Villejuif, France
2LYSARC, LYON, France
3IUCT - Oncopole, Hematology Department, Toulouse, France
4INSERM U1245, Cancer and Brain Genomics, Centre Henri Becquerel, University of Rouen, Rouen, France
5Hematology, CHU Poitiers, Poitiers, FRA
6Centre Henri Becquerel, Department of Hematology, Rouen, France
7Centre Hospitalier Universitaire de Lille - Hopital Claude Huriez, Lille, France
8Hospital Saint-Louis, Paris, France
9Lymphoid Malignancies Department, Henri Mondor University Hospital, AP-HP, Créteil, France
10Centre Antoine-Lacassagne, Nice, FRA

Minyoung Oh1*, Hyungwoo Cho2*, Ji Eun Park3*, Ho Sung Kim3*, Heounjeong Go4*, Chan-Sik Park, MD, PhD4*, Sang-wook Lee5*, Sang Woo Song6*, Young-Hoon Kim6*, Young Hyun Cho7*, Seok Ho Hong6*, Jeong Hoon Kim6*, Dong Yun Lee8*, Jin-Sook Ryu9*, Dok Hyun Yoon, MD, PhD2 and Jae Seung Kim8*

1Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Songpa-Gu, South Korea
2Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
3Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
4Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
5Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
6Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
7Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
8Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
9Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)

Chathuri Abeyakoon, MBBS1, Vanessa Murad, MD2*, Ho-Young Yhim, MD3*, Inna Gong, MD, PhD1, John Kuruvilla, MD, FRCPC1, Michael Crump, MD1*, Anca Prica, MD1, Vishal Kukreti, MD, MSc4, Sita D. Bhella, MD1, Christine I Chen, MHPE, MD5, Chloe Yang, MD6*, Richard Tsang, MD7*, David Hodgson, MD7*, Danielle Rodin, MD, MPH7*, Nauman Malik7*, Woodrow Wells7*, Ur Metser2*, Robert Kridel, MD, PhD1 and Abi Vijenthira, MD, MS1

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
2Department of Medical Imaging, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
3Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea, Republic of (South)
4Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
5Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
6Princess Margaret Cancer Centre, Toronto, ON, Canada
7Division of Radiation Oncology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada

Aban Bahabri, MBBS1,2, Sarah Alexander, MD1*, Cindy Lau, MPH3* and Sumit Gupta, MD, PhD1

1The Hospital For Sick Children, Toronto, ON, Canada
2King Saud University, Riyadh, Saudi Arabia
3ICES, Toronto, Canada

Leyre Bento1*, Fernando Martín Moro2*, Antonio Gutierrez, MD, PhD1*, Ana Jiménez Ubieto3*, Alberto López4*, Blanca Sánchez González5*, Belén Navarro6*, Alicia Segura6*, Mireia Franch7*, Ana García-Noblejas8*, Eva Donato9*, Alejandro Martín García-Sancho10*, Beatriz De La Cruz11*, Alfonso Ortiz Algarra12*, Roberto Trelles-Martínez13*, Javier López14*, Carlos Grande15* and Mariana Bastos-Oreiro16*

1Hematology Department, Son Espases University Hospital, IdISBa, Palma, Spain
2Hematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
3Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
4Hematology Department, Fundación Jiménez Díaz, Madrid, Spain
5Hematology Department, Hospital del Mar, Barcelona, Spain
6Hematology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
7Hematology Department, ICO-IJC-Hospital Germans Trias i Pujol, Barcelona, Spain
8Hematology Department, Hospital La Princesa, Madrid, Spain
9Hematology Department, Hospital Universitario Doctor Peset, Valencia, Spain
10Hematology Department, Salamanca University Hospital, IBSAL, CIBERONC, Salamanca, Spain
11Hematology Department, Hospital Universitario La Paz, Madrid, Spain
12Hematology Department, Hospital Clínico de Valencia, Valencia, Spain
13Hematology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain
14Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain
15Hematology Department, Clínica Universidad de Navarra, Madrid, Spain
16Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Ayako Muramatsu, MD, PhD1,2*, Ayumi Fujimoto, MD3, Koji Izutsu, MD, PhD4, Tsutomu Kobayashi, MD, PhD1*, Takahiro Fukuda5*, Go Yamamoto, MD, PhD6*, Yasufumi Uehara, MD, PhD7*, Masashi Sawa8*, Nobuhiro Hiramoto, MD9*, Tsuyoshi Muta, MD, PhD10*, Keisuke Kataoka, MD, PhD11,12, Yoshinobu Kanda, MD, PhD13,14*, Jun Ishikawa, MD, PhD15*, Makoto Onizuka16, Koji Kawamura, MD, PhD17*, Junya Kanda, MD, PhD18*, Yoshiko Atsuta, MD, PhD19*, Junya Kuroda, MD, PhD2, Shinichi Kako, MD, PhD14 and Ritsuro Suzuki, MD, PhD3

1Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan
2Division of Hematology and Oncology, Department of Medicine,, Kyoto Prefectural University of Medicine, Kyoto, Japan
3Division of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Japan
4National Cancer Center Hospital, Tokyo, Japan
5Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
6Department of Hematology, Toranomon Hospital, Tokyo, Japan
7Department of Hematology, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Kitakyushu, Japan
8Department of Hematology and Oncology, Anjo Kosei Hospital, Anjyo, Japan
9Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
10Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, JPN
11Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
12Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan
13Division of Hematology, Jichi Medical University, Tochigi, Japan
14Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
15Department of Hematology, Osaka International Cancer Institute, Osaka, Japan
16Department of Hematology/Oncology, Tokai University, Isehara, Japan
17Division of Hematology and Clinical Laboratory Medicine, Tottori University Hospital, Yonago, Japan
18Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
19Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan

Chiara Pagani, MD1*, Alessandro Re, MD2*, Simone Maifredi, MD3*, Angela Passi, MD3*, Rosa Daffini, MD3*, Antonella Anastasia, MD3*, Marina Motta, MD3*, Samuele Bagnasco, MD3*, Erika Borlenghi, MD3, Alessia Pantaleo3*, Chiara Aquilina3* and Alessandra Tucci, MD4

1ASST Spedali Civili di Brescia, Brescia, Italy
2Lymphoma Unit, Division of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
3Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
4Hematology, ASST Spedali Civili, Brescia, Italy

Pallawi Torka, MD1, Esther Drill, DrPH1*, Nivetha Ganesan, MPH1*, Regina Truong2*, Annie Qiu1*, Walter Ramos Amador, MPH, MS1*, Mayan Oliveros1*, Alexander P. Boardman, MD2*, Philip Caron, MD2, Kevin A. David, MD2*, Zachary D. Epstein-Peterson, MD2, Lorenzo Falchi, MD1, Paola Ghione, MD, MSEpi1, Steven Horwitz, MD2, Andrew M. Intlekofer, MD, PhD2, William T. Johnson, DO3, Anita Kumar, MD4, Jennifer Kimberly Lue, MD2, Efrat Luttwak, MD2, Alison Moskowitz, MD2, Ariela Noy, MD5, Colette Owens, MD2, Maria Lia Palomba, MD2, Raphael E. Steiner, MD1, Robert Stuver, MD2, Santosha A. Vardhana, MD, PhD2, Andrew D. Zelenetz, MD, PhD2, Gilles Salles, MD, PhD6 and Paul A. Hamlin, MD2

1Memorial Sloan Kettering Cancer Center, New York, NY
2Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
4Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
5Memorial Sloan-Kettering Cancer Ctr., New York, NY
6Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY

Hirohiko Shibayama1*, Atsushi Satake2*, Kohta Miyawaki3*, Yuki Fujiwara4*, Shuichi Ota, MD, PhD5, Tsuyoshi Muta6*, Shinya Rai, MD, PhD7, Hisashi Tsurumi, MD, PhD8, Ritsuro Suzuki, MD, PhD9, Takaaki Miyake10*, Hideki Goto11*, Noriko Fukuhara, MD, PhD12, Mamiko Sakata-Yanagimoto13*, Koji Izutsu, MD, PhD14, Momoko Nishikori15, Takahiro Kumode, MD, PhD16*, Daisuke Ennishi, MD, PhD17, Takayuki Shimose18*, Naoki Inubashiri19*, Itaru Matsumura, MD20, Koichi Akashi, MD, PhD21* and Koji Kato, MD, PhD3

1NHO Osaka National Hospital, Osaka, Japan
2Kansai Medical University, Hirakata, Japan
3Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
4Japanese Red Cross Society Himeji Hospital, Himeji, Japan
5Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
6Hiroshima Red Cross Hospital, Hiroshima, Japan
7Department of Hematology and Rheumatology, Kindai University Hospital, Osaka, Japan
8Matsunami General Hospital, Kasamatsu, Japan
9Division of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Japan
10Shimane Prefectural Central Hospital, Izumo, Japan
11Hokkaido University Hospital, Sapporo, Japan
12Tohoku University Hospital, Miyagi, Japan
13Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
14National Cancer Center Hospital, Tokyo, Japan
15Kyoto University Hospital, Kyoto, Japan
16Department of Hematology and Rheumatology, Kindai University, Osaka, Japan
17Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
18Clinical Research Support Center Kyushu, Fukuoka, Japan
19Chugai Pharmaceutical Co., Ltd., Tokyo, Japan
20Kindai University, Osaka, Japan
21Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan

Bahaa Atamna, MD1,2*, Alon Rozental, MD1,2*, Mohamed Haj Yahia, MD2*, Ronit Gurion1,3*, Moshe Yeshurun, MD1,2*, Pia Raanani, MD1,2 and Ofir Wolach, MD1,2*

1Faculty of medical and health sciences, Tel Aviv University, Tel Aviv, Israel
2Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
3Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel

XI Yang, MD1, Iman Ahmed, PharmD1*, Victoria Nachar, PharmD1*, Shannon A. Carty, MD1, Ryan A. Wilcox, MD, PhD1, Jonathan Weiss, MD1, Dahlia Sano, MBCHB1, Tycel J. Phillips, MD2 and Yasmin H. Karimi, MD1

1Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
2City of Hope, Duarte, CA

Fernando Martín Moro1,2*, Ana Jiménez Ubieto3*, Marina Gomez Llobell, MD, MS4*, Pilar Gómez5*, Miguel Alcoceba6*, Samuel Romero, MD7*, Pau Abrisqueta Costa8*, Paola Villafuerte Gutiérrez9*, Ana Pilar Gonzalez, MD10*, Alberto López11*, Marta Valero Núñez12*, Belén Navarro13*, Raul Cordoba, MD, PhD14, Sofia Huerga15*, Daniel García Belmonte16*, Jimena Cannata17*, Eva Gonzalez Barca18*, Javier López19*, Francisco Díaz20*, Juan-Manuel Sancho, MD, PhD21*, Jose Tomas Navarro, MD, PhD22* and Mariana Bastos-Oreiro23*

1Doctoral Program in Health Sciences, University of Alcala, Alcalá de Henares, Spain
2Hematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
3Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
4Department of Hematology, Gregorio Marañón Hospital, Madrid, NY, Spain
5Hospital La Paz, Madrid, Spain
6Hospital Universitario de Salamanca. (HUS/IBSAL), CIBERONC, and Centro de Investigación del Cáncer (CIC/USAL, Salamanca, Spain
7Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
8University Hospital Vall d’Hebron, Barcelona, Spain
9Hematology Department, Hospital Universitario Principe de Asturias, Madrid, Spain
10Hospital Universitario Central de Asturias, Oviedo, Spain
11Hematology Department, Fundación Jiménez Díaz, Madrid, Spain
12Hospital Arnau de Vilanova, Valencia, Spain
13Hematology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
14Hematology Department, Health Research Institute IIS-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
15Hematology and Cell Therapy Department. Clinica Universidad de Navarra. IdiSNA., Pamplona, Spain
16Hematology Department, Hospital Universitario la Zarzuela, Madrid, Spain
17Hospital de La Princesa, Madrid, Spain
18Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain
19Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain
20Hospital Universitario Gregorio Marañón, Madrid, Spain
21Clinical Hematology Department, ICO-IJC-Hospital Germans Trias i Pujol, Badalona, Spain
22Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Badalona, Spain
23Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain

*signifies non-member of ASH